Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Bradykinin and Masoprocol

supplement:

Masoprocol

Research Papers that Mention the Interaction

The selective CYP 2C9 inhibitor sulfaphenazole and the superoxide anion (O2−) scavengers Tiron and nordihydroguaretic acid also induced a leftward shift in the NO-mediated concentration-relaxation curve to bradykinin.
Circulation research  •  2001  |  View Paper
Bradykinin-induced actin breakdown and cortical actin formation were respectively prevented by indomethacin, a cyclooxygenase inhibitor, and nordihydroguaiaretic acid , a lipoxygenase inhibitor.
Biochemical and biophysical research communications  •  1997  |  View Paper
Methylene blue, a blocker of cytosolic guanylate cyclase and therefore of the production of guanosine 3',5'-cyclic monophosphate (2nd messenger of endothelium-derived relaxing factor, EDRF), and nordihydroguaiaretic acid , an inhibitor of EDRF, both prevented this endothelium-dependent effect of BK.
The American journal of physiology  •  1993  |  View Paper
NDGA caused a moderate inhibition of the bradykinin‐induced prostaglandin release and slightly attenuated the bradykinin relaxation (neither effect of NDGA was statistically significant).
British journal of pharmacology  •  1986  |  View Paper
The lipoxygenase inhibitor, nordihydroguaiaretic acid , inhibited to a similar extent the release of TXA2 by Bk , LTC4 and Paf‐acether but also reduced directly the formation of TXA2 from arachidonic acid, invalidating its use as a specific antilipoxygenase agent.
British journal of pharmacology  •  1984  |  View Paper